Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |